Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Cell culture is the widely accepted and proven methodology for manufacturing recombinant proteins but it can be costly, time-consuming, and inflexible. Chesapeake PERL Inc. (C-PERL)--short for protein expression and recovery labs--is hoping to change this: its mission is to manufacture proteins inexpensively and quickly so it can serve as a contract manufacturer for biopharmaceuticals, especially small-to-midsize firms that require the flexibility of swiftly switching between producing quantities of protein A to protein B.